ọkọlọtọ

Mitoxantrone CAS: 65271-80-9 98% ịdị ọcha

Mitoxantrone CAS: 65271-80-9 98% ịdị ọcha

Nkọwa Dị Mkpirikpi:

Aha Ngwaahịa:Mitoxantrone APIs

Ọdịdị: Ntụ ntụ gbara ọchịchịrị-acha anụnụ anụnụ

Mmiri na-agbaze: Ọ na-agbaze ntakịrị ma ọ bụ ọ fọrọ nke nta ka ọ ghara ịgbaze n'ime mmiri

CAS: 65271-80-9

Usoro Molekụla: C22H28N4O6

Ibu molekụla: 444.5 g/mol


Nkọwa Ngwaahịa

Akara Ngwaahịa

Nkọwa Ngwaahịa

Mitoxantrone (Novantrone) bụ anthraquinone e ji aka mee nke jikọtara ya na anthracyclines n'ụzọ nhazi na n'ụzọ usoro. Ọ na-ejikọta ya na DNA ma na-emepụta mgbawa DNA nke otu eriri. Ọ na-eguzogide ọgwụ na doxorubicin n'ime mkpụrụ ndụ ndị na-eguzogide ọtụtụ ọgwụ na ndị ọrịa na-anaghị anabata ọgwụgwọ doxorubicin.
Mitoxantrone na-arụ ọrụ megide kansa ara, leukemia, na lymphomas. Ọrụ ya na-egbochi etuto ahụ n'ahụ ndị nwere kansa ara dị ntakịrị ala karịa nke doxorubicin. Isi nsí ya bụ myelosuppression; mucositis na afọ ọsịsa nwekwara ike ime. Mitoxantrone na-emepụta obere ọgbụgbọ, alopecia, na nsí obi karịa doxorubicin.

Njirimara Ngwaahịa

Aha Ngwaahịa: Mitoxantrone APIs
Ọdịdị: Ntụ ntụ gbara ọchịchịrị-acha anụnụ anụnụ
Mmiri na-agbaze: Ọ na-agbaze ntakịrị ma ọ bụ ọ fọrọ nke nta ka ọ ghara ịgbaze n'ime mmiri
Nọmba ekwentị: 65271-80-9
Usoro Molekụla: C22H28N4O6
Ibu molekụla: 444.5 g/mol
Aha Kemịkalụ: 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
Ọ dị mma ka onye na-ebuga ozi zigara ya dị ka ngwaahịa nkịtị: ọ dị mma. Ọ dị mma ka e jiri ụgbọelu bufee ya dị ka ngwaahịa nkịtị.
Ịdị ọcha ma ọ bụ Nnwale: 99%
Ụkpụrụ: Ụkpụrụ Ụlọ Ọrụ/USP Ugbu A
Asambodo dị: ISO
Akwụkwọ ndị dị: COA/MSDS
Ike ọkọnọ: 1KG kwa ọnwa
MOQ: 1 Gram

65271-80-9

Ngwa

Mitoxantrone bụ ọgwụ na-eme ka DNA dị n'etiti. Mitoxantrone na-egbochi mmepụta DNA. A na-eji Mitoxantrone eme ihe dị ka ọgwụ mgbochi kansa.
Mitoxantrone nwere ike ịba uru n'ịgwọ ọtụtụ ọrịa neoplastic na nkịta na pusi, gụnyere lymphosarcoma mammary adenocarcinoma, squamous cell carcinoma, renal adenocarcinoma, fibroid sarcoma, thyroid ma ọ bụ transitional cell carcinomas, na hemangiopericytoma.
Ebe ọ bụ na ọgwụ a anaghị ewepụ n'ime akụrụ (10%), enwere ike inye ya nwamba ndị nwere nsogbu akụrụ nke ọma karịa doxorubicin.
Ndị dọkịta na-eji ya agwọ ọrịa kansa prostate na ụfọdụ ụdị leukemia.
Ọ na-arụ ọrụ dị ka ihe mgbochi Topoisomerase.

Nkwakọba na Nchekwa

Nkwakọba: 1g/5g/10g/100g kwa ngwugwu

Nchekwa: Debe n'ebe gbara ọchịchịrị, Emechiri ya na akọrọ, 2-8°C

Nkọwapụta

Aha Mitoxantrone
CAS 65271-80-9
ihe Ọkọlọtọ Nsonaazụ
Ọdịdị Ntụ ntụ gbara ọchịchịrị-acha anụnụ anụnụ Kwekọrọ
Nnyocha, % ≥99 99.1
Mmechi Ndị ruru eru

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a zitere anyị ya